# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4377131 | B | Inhibition of human erythrocytes ADA assessed as reduction in formation of inosine using adenosine as substrate | Homo sapiens | 3 | assay format | Scientific Literature | ||
2. | ALA4377132 | B | Inhibition of human erythrocytes ADA assessed as equilibrium dissociation constant by measuring reduction in formation of inosine using adenosine as substrate | Homo sapiens | 3 | assay format | Scientific Literature | ||
3. | ALA4377133 | B | Inhibition of Plasmodium falciparum N-terminal thrombin cleavable His6-tagged ADA expressed in Escherichia coli BL21 assessed as reduction in formation of inosine using adenosine as substrate | Plasmodium falciparum | 3 | assay format | Scientific Literature | ||
4. | ALA4377134 | B | Inhibition of Plasmodium falciparum N-terminal thrombin cleavable His6-tagged ADA expressed in Escherichia coli BL21 assessed as equilibrium dissociation constant by measuring reduction in formation of inosine using adenosine as substrate | Plasmodium falciparum | 3 | assay format | Scientific Literature | ||
5. | ALA4377135 | B | Selectivity ratio of Ki for inhibition of Plasmodium falciparum N-terminal thrombin cleavable His6-tagged ADA expressed in Escherichia coli BL21 to Ki for inhibition of human erythrocytes ADA | 1 | assay format | Scientific Literature |